FDA approval for Mako Total Knee with Triathlon Tritanium.- Stryker.
Stryker's Joint Replacement division announced that its cementless Mako Total Knee with Triathlon Tritanium has received 510(k) market clearance by the FDA .
Triathlon Tritanium combines the kinematics of Stryker's market leading Triathlon knee implant with the latest in highly porous biologic fixation technology for a knee system like no other. The innovation of Tritanium's tibial baseplate and metal-backed patella components are enabled by Stryker's proprietary AMagine additive manufacturing technology and are SOMA-designed. With cementless procedures rising in popularity and becoming a fast-growing trend, Mako Total Knee with Triathlon Tritanium expands the current robotics offering to provide a cementless solution for orthopaedic surgeons seeking a more predictable surgical experience combined with increased operating room efficiency, biologic fixation and an alternative to bone cement.
.